Drugs / MEBO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07186114 | Mar 2023 → Dec 2024 | mucositis | Cairo University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEBO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07186114 ↗ |
| Route | Topical | “topically applied MEBO® ointment” NCT07186114 ↗ |